Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    Open Studies | "Eye Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Eye Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics
Condition: Endophthalmitis
Intervention: Drug: Topical antibiotics following injection
2 Not yet recruiting Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.
Condition: Endophthalmitis
Interventions: Drug: Moxifloxacin;   Drug: No injection of moxifloxacin
3 Recruiting Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
Condition: Endophthalmitis
Intervention: Drug: Moxifloxacin
4 Recruiting ReSure Sealant Device Exposure Registry
Condition: Endophthalmitis
Intervention: Device: ReSure Sealant
5 Recruiting Cross-linking for Corneal Ulcers Treatment Trial
Conditions: Corneal Ulcer;   Infectious Keratitis;   Bacterial Ulcer;   Fungal Ulcer
Interventions: Procedure: Bacterial ulcer cross-linking;   Procedure: Bacterial ulcer control;   Procedure: Fungal ulcer cross-linking;   Procedure: Fungal ulcer control
6 Not yet recruiting Intracameral Antibiotic Safety Study
Conditions: Intracameral Antibiotics;   Cataract Surgery;   Phacoemulsification;   Endophthalmitis;   Vancomycin;   Moxifloxacin
Interventions: Drug: Vancomycin;   Drug: Moxifloxacin;   Drug: Placebo
7 Recruiting Targeted PCR and Acute Endophthalmitis
Condition: Acute Endophthalmitis Post-operative
Interventions: Biological: PCR : 16S ribosomal DNA and real-time targeted PCR;   Biological: Sampling of aqueous humour
8 Recruiting Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty
Conditions: Corneal Ulcer;   Leukoma
Intervention: Device: Collagen-MPC cornea
9 Recruiting Village Integrated Eye Workers Trial
Condition: Corneal Ulcer
Intervention: Other: Corneal ulcer prevention program
10 Recruiting Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer
Conditions: Keratitis;   Corneal Ulcer
Intervention: Device: T4020
11 Recruiting Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Vancomycin 1.1%;   Drug: Placebo
12 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
13 Recruiting Topical Anesthesia for Closed PKP vs Retrobulbar Anesthesia for Open-sky PKP
Conditions: Corneal Opacity;   Keratitis, Herpetic;   Corneal Ulcer;   Corneal Dystrophies, Hereditary
Interventions: Procedure: closed PKP under topical anesthesia;   Procedure: open-sky PKP under retrobulbar anesthesia;   Drug: Anti-Rejection Agents;   Drug: Anti-Inflammatory Agents
14 Not yet recruiting Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: PVP-I 0.6%;   Drug: Placebo
15 Recruiting Sanitation, Water, and Instruction in Face-washing for Trachoma
Condition: Trachoma
Interventions: Behavioral: Water, sanitation, and hygiene (WASH) intervention;   Behavioral: Standard of care WASH intervention;   Drug: Azithromycin;   Drug: Tetracycline;   Other: Control
16 Recruiting Water Uptake for Health in Amhara Pilot
Condition: Trachoma
Intervention: Behavioral: instruction in soap-making and hygiene education
17 Recruiting Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years
Condition: Acanthamoeba Keratitis
Intervention: Other: no intervention
18 Not yet recruiting Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Condition: Adenoviral Conjunctivitis
Interventions: Drug: Iota-Carrageenan;   Drug: Carmellose
19 Not yet recruiting Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: Placebo
20 Not yet recruiting Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Condition: Adenoviral Conjunctivitis
Interventions: Drug: SHP640;   Drug: PVP-I 0.6%;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.